Market Research Future (MRFR) has published on the “Global DNA synthesis Market”.

The DNA synthesis market is estimated to register a CAGR of 20.50%during the forecast period of 2023 to 2032.

MRFR recognizes the following companies as the key players in the DNA synthesis market— GC Biosearch Technologie, Bioneer Corporation, Thermo Fisher Scientific, Inc., IBA GmbH, Twist Bioscience, Eton Bioscience, Quintara Biosciences, Eurofins Scientific, Integrated DNA Technologies, Inc., GenScript Biotech Corporation.

DNA synthesis Market Highlights

The DNA synthesis market is accounted to register a CAGR of 20.50% during the forecast period and is estimated to reach USD 13.39 billion by 2032.

The DNA synthesis market is driven by the increasing demand for synthetic DNA in various applications such as genetic engineering, molecular biology, and synthetic biology. However, regulatory challenges and ethical concerns regarding gene editing technologies restrain market growth. Opportunities lie in the development of advanced synthesis techniques and applications in personalized medicine and gene therapy. Challenges include the high cost of synthesis and the need for stringent quality control measures.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Dna Synthesis Market 

Segment Analysis

The DNA synthesis market has been segmented into service, application, and end-user.

On the basis of service, the market is segmented into oligonucleotide synthesis, gene synthesis. The oligonucleotide synthesis segment was attributed to holding the largest market share in 2022 due to the widespread use of oligonucleotides in various research, diagnostic, and therapeutic applications.

Based on application, the DNA synthesis market has been segmented into research and development, therapeutics, diagnostic. The research and development segment was expected to hold the largest market share in 2022. Due to the extensive use of synthesized DNA in laboratory studies, experimental research, and biotechnological advancements..

Based on end-user, the DNA synthesis market has been segmented into biopharmaceutical companies, academic and research institutes, contract research organizations. The Biopharmaceutical Companies segment was expected to hold the largest market share in 2022. The dominating end-user category is Biopharmaceutical Companies, holding a significant market share due to their substantial investments in research and development of novel therapeutics, diagnostics, and biotechnological products.

Regional Analysis

The DNA synthesis market, based on region, has been divided into the North America, Europe, Asia-Pacific, and Rest of the World. North America consists of US and Canada. The Europe DNA synthesis market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe. The DNA synthesis market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World DNA synthesis market comprises of Middle East, Africa, and Latin America.

The largest market share for DNA synthesis was maintained by the North American regional sector.This increase is attributed to robust infrastructure for scientific research, including advanced laboratory facilities and academic institutions, further fueling the demand for DNA synthesis. Moreover, North America's favorable regulatory environment and strong intellectual property protection encourage innovation in the field, attracting both domestic and international players to establish a significant presence in the market.

Moreover, the Europe market has been persistently growing over the forecast period. The demand for DNA synthesis is driven by supportive government policies and funding initiatives for scientific research and development contribute to the growth of the DNA synthesis market in the region. Moreover, Europe benefits from a skilled workforce and collaborative research networks, fostering a conducive environment for advancements in DNA synthesis technologies and applications.

Additionally, Asia Pacific is anticipated to experience the quickest growth in the DNA synthesis market due to several factors. Firstly, the region is witnessing rapid advancements in biotechnology and genomics, driven by increasing investments in research and development. Additionally, rising healthcare expenditure, growing awareness about personalized medicine, and expanding applications of DNA synthesis in agriculture, pharmaceuticals, and biotechnology sectors further propel market growth in Asia Pacific.

Furthermore, the rest of the world's DNA synthesis market is divided into the Middle East, Africa, and Latin America. This growth is attributed to the growing interest and investment in biotechnology and life sciences research in these regions. Although these regions may have smaller market shares compared to North America, Europe, and Asia Pacific, there is increasing recognition of the importance of genomics and DNA synthesis in various fields such as healthcare, agriculture, and environmental sciences.

Key Findings of the Study

• The DNA synthesis market is expected to reach USD 13.39 billion by 2032, at a CAGR of 20.50% during the forecast period.


• The Asia-Pacific region accounted for the fastest-growing global market due to the increasing investments in research and development.


• Based on end-user, the biopharmaceutical companies segment was attributed to holding the largest market in 2022, with an approximate market share of 35–50%.


• GC Biosearch Technologie, Bioneer Corporation, Thermo Fisher Scientific, Inc., IBA GmbH, Twist Bioscience, Eton Bioscience, Quintara Biosciences, Eurofins Scientific, Integrated DNA Technologies, Inc., GenScript Biotech Corporation.